(Q41526545)

English

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

scientific article published on 20 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

0 references

Gili Regev-Yochay

1

object named as

Gili Regev-Yochay

0 references

12

object named as

Ron Dagan

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

11

object named as

Galia Rahav

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

author name string

Yael Paran

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Jihad Bishara

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Ilana Oren

4

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Michal Chowers

5

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Yevgenia Tziba

6

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Valery Istomin

7

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Miriam Weinberger

8

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Dan Miron

9

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Violeta Temper

10

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

IAIPD group

13

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

language of work or name

0 references

publication date

20 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1135-1142

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

The spectrum of pneumococcal empyema in adults in the early 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Impact of conjugate pneumococcal vaccines on antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.030

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.01.030

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41526545&oldid=1923694881"